Title(s):
Professor of Medicine
Director of Johns Hopkins Ciccarone Preventive Cardiology Center
Appointment Phone:
443-997-0270
Primary Location:
The Johns Hopkins Hospital
Expertise:
Cardiology, Cardiovascular Computed Tomography, Cardiovascular Disease, Cardiovascular Disease in Women, Cardiovascular Risk Stratification, Chest pain, Clinical Cardiology, Coronary Artery Disease, Coronary CT Angiography, Dyslipidemia and Hypertension, General Cardiology, Heart Disease, Heart Disease Prevention and Treatment in Women, High Cholesterol, Hypertension, Ischemic Heart Disease, Preventive Cardiology, Stress Testing
Education and Experience
Training
- Cornell University Medical College (Ithaca NY)/ (1985)
Residencies
- Johns Hopkins University School of Medicine (Baltimore MD)/ Internal Medicine (1988)
Fellowships
- Johns Hopkins University School of Medicine (Baltimore MD)/ Cardiology (1992)
Certifications
- Cardiovascular Disease, American Board of Internal Medicine (2003)
- Internal Medicine, American Board of Internal Medicine (1988)
Locations
The Johns Hopkins Hospital
600 N. Wolfe Street
Blalock Building Room 524-C
Baltimore, MD 21287
Phone: 410-955-7376
Appointment Phone: 443-997-0270
Fax: 410-614-9190
Location Map
Johns Hopkins Medicine - Green Spring Station
10755 Falls Road
Ciccarone Center, Pavilion I Room 360
Lutherville, MD 21093
Phone: 410-583-2738
Appointment Phone: 443-997-0270
Fax: 410-583-2741
Location Map
Johns Hopkins Outpatient Center
601 N. Caroline Street
Baltimore, MD 21287
Phone: 410-955-7376
Appointment Phone: 443-997-0270
Fax: 410-614-9190
Location Map
Department / Division
-
Medicine - Cardiology
Centers/Institutes
Centers / Institutes
- Ciccarone Center for Preventive Cardiology
- Heart and Vascular Institute
Bio
Biography
Dr. Blumenthal's principal clinical and research interests involve the optimal management of ischemic heart disease, noninvasive detection of coronary atherosclerosis, and the development of new strategies to optimize the management of cardiovascular disease risk factors. Dr. Blumenthal specializes in treating adults who are at higher risk for future cardiovascular events because of 1) a history of prior cardiovascular or peripheral arterial disease or 2) the presence of multiple coronary risk factors.
Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, and he is the Director of Preventive Cardiology at Johns Hopkins. He is a member of the official national spokesperson panel for the American Heart Association (A.H.A.).
An experienced writer, Dr. Blumenthal is on the editorial board of The American Heart Journal, Clinical Cardiology and the American College of Cardiology Extended Learning Center (ACCEL). He is the Preventive Cardiology/Coronary Heart Disease section editor of Cardiology Today. He is editor of the annual Johns Hopkins White Paper on Prevention of Heart Disease.
Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, and he is the Director of Preventive Cardiology at Johns Hopkins. He is a member of the official national spokesperson panel for the American Heart Association (A.H.A.).
An experienced writer, Dr. Blumenthal is on the editorial board of The American Heart Journal, Clinical Cardiology and the American College of Cardiology Extended Learning Center (ACCEL). He is the Preventive Cardiology/Coronary Heart Disease section editor of Cardiology Today. He is editor of the annual Johns Hopkins White Paper on Prevention of Heart Disease.
Physician Title
Director of Johns Hopkins Ciccarone Preventive Cardiology Center
Awards and Honors
Member of NIH Cardiology Committee National Program to Reduce Cardiovascular Risk (2011-2013)
Named One of Baltimore Magazine's Top Cardiologist (2010, 2012)
President of American Heart Association, Greater Baltimore Chapter (2012)
Named one of US News and World Reports Top Doctors (2011)
Recipient of the David Levine Mentorship Award in Johns Hopkins Department of Medicine (2010)
Selected as One of the Top Cardiologist in American by Men's Health Magzine (2007, 2008)
Chairman, American College of Cardiology Committee for Prevention of Cardiovascular Disease (2005-2009)
Past President, American Heart Association, Maryland Council (2001)
Member of American Heart Association, National Spokespersons Panels.
Recipient of American Heart Association Maryland Affiliate Presidential Recognition Award and the Unsung Hero Award.
Named One of Baltimore Magazine's Top Cardiologist (2010, 2012)
President of American Heart Association, Greater Baltimore Chapter (2012)
Named one of US News and World Reports Top Doctors (2011)
Recipient of the David Levine Mentorship Award in Johns Hopkins Department of Medicine (2010)
Selected as One of the Top Cardiologist in American by Men's Health Magzine (2007, 2008)
Chairman, American College of Cardiology Committee for Prevention of Cardiovascular Disease (2005-2009)
Past President, American Heart Association, Maryland Council (2001)
Member of American Heart Association, National Spokespersons Panels.
Recipient of American Heart Association Maryland Affiliate Presidential Recognition Award and the Unsung Hero Award.
Expertise
- Cardiology
- Cardiovascular Computed Tomography
- Cardiovascular Disease
- Cardiovascular Disease in Women
- Cardiovascular Risk Stratification
- Chest pain
- Clinical Cardiology
- Coronary Artery Disease
- Coronary CT Angiography
- Dyslipidemia and Hypertension
- General Cardiology
- Heart Disease
- Heart Disease Prevention and Treatment in Women
- High Cholesterol
- Hypertension
- Ischemic Heart Disease
- Preventive Cardiology
- Stress Testing
Professional Highlights
Past Chair of American College of Cardiology Committee on Prevention of Cardiovascular Diseases
Past Chair of Hypertension, Vascular, and Prevention Section of the 2006 American College of Cardiology Scientific Sessions
Medical Director, 2002 U.S. Senior Open
Past President, American Heart Association Maryland Affiliate
Current Member, American Heart Association Expert Panel on Subclinical Atherosclerotic Disease and Emerging Risk Factors.
Chairman, American College of Cardiology Foundation COCATS Update for Training in Preventive Cardiovascular Medicine.
Past member of NHLBI Working Working on the Integrative Approach to Identify Patients at High Risk of a Cardiovascular Event in the Near Future.
Past Chair of Hypertension, Vascular, and Prevention Section of the 2006 American College of Cardiology Scientific Sessions
Medical Director, 2002 U.S. Senior Open
Past President, American Heart Association Maryland Affiliate
Current Member, American Heart Association Expert Panel on Subclinical Atherosclerotic Disease and Emerging Risk Factors.
Chairman, American College of Cardiology Foundation COCATS Update for Training in Preventive Cardiovascular Medicine.
Past member of NHLBI Working Working on the Integrative Approach to Identify Patients at High Risk of a Cardiovascular Event in the Near Future.
Research
Research and Publications
1. Gluckman TJ, Sachdev M, Schulman SP, Blumenthal RS. A Simplified Approach to the Management of Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA. 2005; 293:349-357.
2. Mora S, Redberg RF, Sharrett AR, Blumenthal RS. Enhanced Risk Assessment in Asymptomatic Individuals Using Exercise Testing and Framingham Risk Scores. Circulation. 2005;112:1566-72.
3. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, Blumenthal RS. Framingham Risk Equation Underestimates Subclinical Atherosclerosis Risk in Asymptomatic Women. Atherosclerosis. 2006; 184:201-206.
4. Nasir K, Budoff MJ, Wong ND, Scheuner M, Herrington D, Arnett DK, Szklo M, Greenland P, Blumenthal RS. Family History of Premature Coronary Heart Disease and Coronary Artery Calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;116:619-26.
5. Blumenthal RS, Michos ED, Nasir K. Further Improvements in CHD Risk Prediction for Women. JAMA. 2007; 297:641-3.
6. Lakoski SG, Greenland PG, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K, Blumenthal RS.
Coronary Artery Calcium Scores and Risk for Cardiovascular Events in Women Classified as Low Risk Based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2007;167:2437-2442.
7. Michos ED, Blumenthal RS. Prevalence of Low Low-Density Lipoprotein Cholesterol with Elevated High-Sensitivity C-reactive Protein in the U.S.- Implications of the JUPITER Study. J Am Coll Cardiol. 2009; 53:931-5.
8. Blumenthal RS, Michos ED. The HALTS Trial Halting Atherosclerosis or Halted Too Early? N Engl J Med. 2009; 361:2178-90.
9. Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, Shea S, Limia JAC, Blumenthal RS. Cardiovascular Events with Absent or Minimal Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009; 158:554-61.
10. Weiss SA, Blumenthal RS, Sharrett AR, Redberg RF, Mora S. Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals. Circulation. 2010; 121: 2109-16.
11. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for Cardiovascular Risk in Asymptomatic Patients. J Am Coll Cardiol. 2010; 55:1169-72.
12. Silverman MG, Blaha MJ, Blumenthal RS. Adjunctive Lipid Lowering Therapy in the Era of Surrogate Endpoints. Cardiol Rev. 2011;17-22.
13. Blankstein R, Budoff MJ, Shaw LJ, Goff DC, Polak JF, Lima J, Blumenthal RS, Nasir K. Predictors of Coronary Heart Disease Events Among Asymptomatic Individuals with Low LDL Cholesterol; MESA. J Am Coll Cardiol. 2011; 58:364-74.
14. Blaha MJ, Budoff MJ, DeFilippis AP, Blankstein R, Rivera JJ, Agatston A, OLeary DH, Lima J, Blumenthal RS, Nasir K. Associations Between C-Reactive Protein, Coronary Artery Calcium, and Cardiovascular Events, and Implications for the JUPITER Population in MESA: A Population-Based Cohort Study. Lancet. 2011;378:684-92.
15. Blaha MJ, Blumenthal RS, Budoff MJ, Nasir K. Understanding the Utility of Zero Coronary Calcium As a Prognostic Test: A Bayesian Approach. Circ Cardiovasc Qual Outcomes. 2011;4:253-6.
16. Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of Physical Activity on Cardiovascular Disease. Am J Cardiol. 2012;109:288-95.
17. Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based Use of Statins For Primary Prevention of Cardiovascular Disease. Am J Med. 2012;125:440-6.
18. Michos ED, Blumenthal RS. How Accurate are 3 Risk Prediction Models in US Women? Circulation. 2012;125:1723-6.
19. Blaha MJ, Nasir K, Blumenthal RS. Statin Therapy for Healthy Men Identified as Increased Risk. JAMA. 2012;307:1489-90.
20. Michos ED, Sibley CT, Baer JT, Blaha MJ, Blumenthal RS. Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events: Reconciling the AIM-HIGH Trial with Previous Surrogate Endpoint Trials. J Am Coll Cardiol. 2012;59:2058-64.
Subclinical atherosclerosis as measured by Cardiac CT or carotid ultrasound.
Individuals with a family history of heart disease.
Heart Disease in Women
Cardiac Computed Tomography
Primary and secondary prevention of coronary heart disease.
Hyperlipidemia
2. Mora S, Redberg RF, Sharrett AR, Blumenthal RS. Enhanced Risk Assessment in Asymptomatic Individuals Using Exercise Testing and Framingham Risk Scores. Circulation. 2005;112:1566-72.
3. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, Blumenthal RS. Framingham Risk Equation Underestimates Subclinical Atherosclerosis Risk in Asymptomatic Women. Atherosclerosis. 2006; 184:201-206.
4. Nasir K, Budoff MJ, Wong ND, Scheuner M, Herrington D, Arnett DK, Szklo M, Greenland P, Blumenthal RS. Family History of Premature Coronary Heart Disease and Coronary Artery Calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;116:619-26.
5. Blumenthal RS, Michos ED, Nasir K. Further Improvements in CHD Risk Prediction for Women. JAMA. 2007; 297:641-3.
6. Lakoski SG, Greenland PG, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K, Blumenthal RS.
Coronary Artery Calcium Scores and Risk for Cardiovascular Events in Women Classified as Low Risk Based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2007;167:2437-2442.
7. Michos ED, Blumenthal RS. Prevalence of Low Low-Density Lipoprotein Cholesterol with Elevated High-Sensitivity C-reactive Protein in the U.S.- Implications of the JUPITER Study. J Am Coll Cardiol. 2009; 53:931-5.
8. Blumenthal RS, Michos ED. The HALTS Trial Halting Atherosclerosis or Halted Too Early? N Engl J Med. 2009; 361:2178-90.
9. Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, Shea S, Limia JAC, Blumenthal RS. Cardiovascular Events with Absent or Minimal Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009; 158:554-61.
10. Weiss SA, Blumenthal RS, Sharrett AR, Redberg RF, Mora S. Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals. Circulation. 2010; 121: 2109-16.
11. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for Cardiovascular Risk in Asymptomatic Patients. J Am Coll Cardiol. 2010; 55:1169-72.
12. Silverman MG, Blaha MJ, Blumenthal RS. Adjunctive Lipid Lowering Therapy in the Era of Surrogate Endpoints. Cardiol Rev. 2011;17-22.
13. Blankstein R, Budoff MJ, Shaw LJ, Goff DC, Polak JF, Lima J, Blumenthal RS, Nasir K. Predictors of Coronary Heart Disease Events Among Asymptomatic Individuals with Low LDL Cholesterol; MESA. J Am Coll Cardiol. 2011; 58:364-74.
14. Blaha MJ, Budoff MJ, DeFilippis AP, Blankstein R, Rivera JJ, Agatston A, OLeary DH, Lima J, Blumenthal RS, Nasir K. Associations Between C-Reactive Protein, Coronary Artery Calcium, and Cardiovascular Events, and Implications for the JUPITER Population in MESA: A Population-Based Cohort Study. Lancet. 2011;378:684-92.
15. Blaha MJ, Blumenthal RS, Budoff MJ, Nasir K. Understanding the Utility of Zero Coronary Calcium As a Prognostic Test: A Bayesian Approach. Circ Cardiovasc Qual Outcomes. 2011;4:253-6.
16. Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of Physical Activity on Cardiovascular Disease. Am J Cardiol. 2012;109:288-95.
17. Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based Use of Statins For Primary Prevention of Cardiovascular Disease. Am J Med. 2012;125:440-6.
18. Michos ED, Blumenthal RS. How Accurate are 3 Risk Prediction Models in US Women? Circulation. 2012;125:1723-6.
19. Blaha MJ, Nasir K, Blumenthal RS. Statin Therapy for Healthy Men Identified as Increased Risk. JAMA. 2012;307:1489-90.
20. Michos ED, Sibley CT, Baer JT, Blaha MJ, Blumenthal RS. Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events: Reconciling the AIM-HIGH Trial with Previous Surrogate Endpoint Trials. J Am Coll Cardiol. 2012;59:2058-64.
Subclinical atherosclerosis as measured by Cardiac CT or carotid ultrasound.
Individuals with a family history of heart disease.
Heart Disease in Women
Cardiac Computed Tomography
Primary and secondary prevention of coronary heart disease.
Hyperlipidemia
Research Interests
- Improved strategies for management of cardiovascular risk factors
- Subclinical coronary atherosclerosis as measured by Cardiac CT
- Individuals with a family history of heart disease
- Heart Disease in Women
- Cardiac Computed Tomography
- Primary and secondary prevention of coronary heart disease
- Hyperlipidemia
- Cardiovascular Risk Assessment
More Info
Languages
- English
Memberships
Fellow, American College of Cardiology
Fellow, American Heart Association
The Johns Hopkins Medical and Surgical Association
International Atherosclerosis Society
Clinical Trials:
Hyperlipidemia, Subclinical Atherosclerosis
Fellow, American Heart Association
The Johns Hopkins Medical and Surgical Association
International Atherosclerosis Society
Clinical Trials:
Hyperlipidemia, Subclinical Atherosclerosis
Clinical Trials
- Hyperlipidemia, Subclinical atherosclerosis
Additional Resources
Videos and Podcasts
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts